Eckert & Ziegler Strahlen- und Medizintechnik AG

M&A Activity • Jun 30, 2005

News Details

Ad-hoc | 30 June 2005 12:02

Eckert & Ziegler AG to Acquire f-con Europe GmbH

Ad hoc announcement §15 WpHG Acquisitions Eckert & Ziegler AG to Acquire f-con Europe GmbH Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— Berlin, 30.06.2005. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in radioactive components for medical and in- dustrial use will acquire 51% of the shares of f-con Europe GmbH, as of July 1, 2005. In order to differentiate from the Austrian f-con group the com- pany’s name will be changed to Eckert & Ziegler f-con Europe GmbH. The Hesse based company distributes radioactive glucose (PET tracer) through its subsidiaries in Germany and Italy. The radioactive glucose is used to di- agnose cancer with the so called Positron Emission Tomography (PET). In 2004 the company achieved sales of approximately 3 Mio EUR. The general manager of Eckert & Ziegler f-con Europe GmbH will be Axel Schmidt, a radio chemist with long standing expert knowledge, who brings an experienced team into the group. The Executive Board For further questions please contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany Phone: +49 (0)30 / 94 10 84-138 http://www.ezag.de ECKERT & ZIEGLER Strahlen- und Medizintechnik AG Robert-Rössle-Str. 10 13125 Berlin Deutschland ISIN: DE0005659700 WKN: 565970 Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart End of ad hoc announcement (c)DGAP 30.06.2005 301202 Jun 05